Live

L

$LNTH

3 articles found

2 positive

0 negative

1 neutral

Radiopharmaceuticals Market to Double to $15.21B by 2035 Amid Cancer Surge

GlobeNewswire Inc.

GlobeNewswire Inc.·Apr 24·Precedence Research

Radiopharmaceuticals Market to Double to $15.21B by 2035 Amid Cancer Surge

Global radiopharmaceuticals market projected to grow from $8.28B (2026) to $15.21B (2035) amid rising cancer and cardiovascular disease incidence.

LLYCAHNVSLNTHSIEGY+1cancer treatmentradiopharmaceuticals

Lantheus Shifts Strategy, Posts $1.54B in 2025 Revenue Amid Pipeline Expansion

GlobeNewswire Inc.

GlobeNewswire Inc.·Feb 26·Na

Lantheus Shifts Strategy, Posts $1.54B in 2025 Revenue Amid Pipeline Expansion

Lantheus posted $1.54B in 2025 revenue but faces Q4 headwinds. The company plans to refocus on PET diagnostics while exploring options for radiotherapy assets, expecting four FDA approvals in 2026.

LNTHearningsacquisitions

PYLARIFY Makes History as First Blockbuster Radiodiagnostic Amid PSMA Market Expansion

GlobeNewswire Inc.

GlobeNewswire Inc.·Feb 20·Researchandmarkets.Com

PYLARIFY Makes History as First Blockbuster Radiodiagnostic Amid PSMA Market Expansion

PYLARIFY becomes first radiodiagnostic to exceed $1 billion in annual sales with 24% growth, as PSMA-targeted prostate cancer treatments gain significant market momentum.

NVSLNTHPET imagingPYLARIFY